user
cart
menu
orderQuote Inquiry / OrdercartCart
letter
Sign InRegister
langEnglisharrow

IgG3 Fc

IgG3 Fc

IgG3 Fc Informations sur la molécule

Molecule Name
Immunoglobulin G
Alias de la molécule
Ig gamma-3 chain C region,IgG,IgG3
Drug Development Progress
Nombre de médicaments cliniques8
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
Immunoglobulin G
Contexte de la molécule
Immunoglobulin G3 (IgG3) is a member of many immunoglobulin G developed and secreted by effective B cells. In wake of cutting by pepsin, IgG is divided into two F(ab)s with one antigen binding site and a high conserved Fc segment. The Fc segment bears a highly conserved N-glycosylation site. Ig gamma-3 chain C region (IgG3-Fc / IGHG3) contains two constant regions of IgG3 H chain (CH2, CH3).

IgG3 Fc Liste de produits

Species
  • Human（2）
  • Mouse（1）
Tag
  • Tag Free（2）
  • Avi Tag（1）
Host
  • HEK293（3）
Conjugate
  • Unconjugated（2）
  • Biotin-labeled（1）
Grade
  • RUO（3）
Low Endotoxin
  • No（3）
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
IgG3 Fc
IG3-H5200
Human IgG3 Fc Protein, Tag Free (MALS & SPR verified)
Human
HEK293
MALSSDS-PAGE
SPR

$280.00

200ug
IgG3 Fc
Avitag
IG3-H8213
Biotinylated Human IgG3 Fc Protein, Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
IgG3 Fc
IG3-M5214
Mouse IgG3 Fc Protein, Tag Free (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$325.00

200ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Demande de produitRequest Customization
Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
RicefidaseKJ-103; KJ103Phase 3 ClinicalShanghai Bao Pharmaceuticals Co Ltd
Anti-Glomerular Basement Membrane Disease; Guillain-Barre Syndrome; Rejection of renal transplantation
Details
AT-02AT-02Phase 2 ClinicalAttralus Inc
Amyloidosis; Immunoglobulin Light-chain Amyloidosis
Details
JZB-34AAFP; JZB-34Phase 1 ClinicalShanghai Kexin Biotech Co Ltd
Hypersensitivity
Details
Emicizumab biosimilar (Jushi Biopharmaceutical)SYS6053; SYS-6053Phase 1 ClinicalJushi Biopharmaceutical Co Ltd
Hemophilia A; Hemorrhage
Details
S-1117S-1117Phase 1 ClinicalSeismic Therapeutics Inc
Immune System Diseases
Details
BHV-1300BHV-1300Phase 1 ClinicalBiohaven Pharmaceuticals Inc
Arthritis, Rheumatoid; Graves Disease
Details
HNSA-5487HNSA 5487; HNSA-5487Phase 1 ClinicalHansa Biopharma Ab
Autoimmune Diseases; Neoplasms
Details
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD)Phase 1 ClinicalUniversity Of California San Diego
Leukemia, Myeloid, Acute
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
ImlifidaseMac-1ApprovedHansamed IncIdefirixEURejection of renal transplantationHansa Biopharma Ab2020-08-25
Guillain-Barre Syndrome; Kidney Diseases; Kidney Failure, Chronic; Purpura, Thrombotic Thrombocytopenic; Rejection of renal transplantation; Rejection of organ transplantation; Renal Insufficiency, Chronic
Details
Customer Reviews